Martin Lange

Corporate Officer/Principal at NOVO NORDISK A/S

54 year

Health Technology

Consumer Services

Profile

Martin Holst Lange is currently the Director at Pharmacosmos A since 2023 and the Executive Vice President-Development at Novo Nordisk A since 2021.
Previously, he worked as the Director at Novo Nordisk, Inc. from 2006 to 2008 and as the Director at Beta Bionics, Inc. from 2017 to 2020.
Dr. Lange holds multiple doctorate degrees from the University of Copenhagen, conferred in 1997 and 2004.

Martin Lange active positions

Companies	Position	Start
NOVO NORDISK A/S	Corporate Officer/Principal	01/01/2018
Pharmacosmos A/S Pharmacosmos A/S Pharmaceuticals: MajorHealth Technology Pharmacosmos A/S develops treatments of iron deficiency anemia in humans and animals. Its products include monofer, cosmofer, diafer and uniferon. The company was founded by Dr. Henry M. Christensen in 1965 and is headquartered in Holbæk, Denmark.	Director/Board Member	18/08/2023

All active positions of Martin Lange

Former positions of Martin Lange

Companies	Position	End
Beta Bionics, Inc. Beta Bionics, Inc. Medical SpecialtiesHealth Technology Beta Bionics, Inc. operates a medical technology company leveraging lifelong, machine-learning, artificial intelligence to develop and commercialize the autonomous bionic pancreas. The company was founded by Edward R. Damiano in October 21, 2015 and is headquartered in Boston, MA.	Director/Board Member	20/02/2020
Novo Nordisk, Inc. Novo Nordisk, Inc. BiotechnologyHealth Technology Novo Nordisk, Inc. operates diabetes care company. It offers biopharmaceuticals, chronic weight management, human growth hormone therapy and hemophilla management services. The firm also provides rare bleeding disorders, growth hormone related disorders, and women's health. The company was founded in 1982 and is headquartered in Plainsboro, NJ.	Director/Board Member	01/01/2008

See the detail of Martin Lange's experience

Training of Martin Lange

University of Copenhagen

Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Martin Lange's experience

Connections

100 +

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
NOVO NORDISK A/S	Health Technology

Private companies	3
Novo Nordisk, Inc. Novo Nordisk, Inc. BiotechnologyHealth Technology Novo Nordisk, Inc. operates diabetes care company. It offers biopharmaceuticals, chronic weight management, human growth hormone therapy and hemophilla management services. The firm also provides rare bleeding disorders, growth hormone related disorders, and women's health. The company was founded in 1982 and is headquartered in Plainsboro, NJ.	Health Technology
Beta Bionics, Inc. Beta Bionics, Inc. Medical SpecialtiesHealth Technology Beta Bionics, Inc. operates a medical technology company leveraging lifelong, machine-learning, artificial intelligence to develop and commercialize the autonomous bionic pancreas. The company was founded by Edward R. Damiano in October 21, 2015 and is headquartered in Boston, MA.	Health Technology
Pharmacosmos A/S Pharmacosmos A/S Pharmaceuticals: MajorHealth Technology Pharmacosmos A/S develops treatments of iron deficiency anemia in humans and animals. Its products include monofer, cosmofer, diafer and uniferon. The company was founded by Dr. Henry M. Christensen in 1965 and is headquartered in Holbæk, Denmark.	Health Technology

See company connections

Stock Market
Insiders
Martin Lange